In the January issue of Applied Clinical Trials, an author was inadvertently omitted from the article "Seeking Guidance on Rater Reliability."
Marian A. Ormont, M.D., F.A.P.M., Medical Director of ePharmaSolutions, email: mormont@epharmasolutions.com, was co-author to this article. Dr. Ormont recently joined ePharmaSolutions to support the company's expansion of its global CNS Rater Services Department.
Applied Clinical Trials sincerely regrets this error.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Gilead Shares Final Data from Phase III MYR301 Trial of Bulevirtide in Chronic Hepatitis Delta Virus
May 7th 2025Long-term results from the study show 90% of patients with chronic HDV who achieved undetectable HDV RNA at 96 weeks of treatment remained undetectable for nearly 2 years post-treatment.